Chapter II Neurobiology and neuropathology of the human hypothalamus

Handbook of Chemical Neuroanatomy

Volumn 13, Issue , 1997, Pages 39-137

  Swaab, D F ^a  

^a NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350727149     PISSN: 09248196     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0924-8196(97)80004-8     Document Type: Article

References (498)

1. Abe J., Okamura H., Kitamura T., Ibata Y., Minamino N., Matsuo H., and Paull W.K. Immunocytochemical demonstration of dynorphin (PH-8P)-like immunoreactive elements in the human hypothalamus. J. Comp. Neurol. 276 (1988) 508-513
2. Abe J., Okamuro H., Motoyama A., Wakabayashi I., Ling N., and Paull W.K. Immunocytochemical demonstration of GAP-like immunoreactive neuronal elements in the human hypothalamus and pituitary. Histochemistry 94 (1990) 127-133
3. Abernethy W.B., Bell M.A., Morris M., and Moody D.M. Microvascular density of the human paraventricular nucleus decreases with aging but not hypertension. Exp. Neurol. 121 (1993) 270-274
4. Airaksinen M.S., Partau A., Paljärvi L., Reinikainen K., Riekkinen P., Suomalainen R., and Panula P. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neurosci. 44 (1991) 465-481
5. Alheid G.F., Heimer L., and Switzer R.C. Basal ganglia. In: Paxinos G. (Ed). The Human Nervous System (1990), Academic Press, Cambridge, MA 508-510
6. Allen S.J., Dowbarn D., and Wilcock G.K. Morphometrical immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Brain Res. 454 (1988) 272-281
7. Allen L.S., Hines M., Shryne J.E., and Gorski R.A. Sex difference in the bed nucleus of the stria terminalis of the human brain. J. Comp. Neurol. 302 (1989) 697-706
8. Allen L.S., Hines M., Shryne J.E., and Gorski R.A. Two sexually dimorphic cell groups in the human brain. J. Neurosci. 9 2 (1989) 497-506
9. Allen L.S., and Gorski R.A. Sexual dimorphism of the anterior commissure and massa intermedia of the human brain. J. Comp. Neurol. 312 (1991) 97-104
10. Allen L.S., and Gorski R.A. Sexual orientation and the size of the anterior commissure in the human brain. Proc. Natl. Acad. Sci. USA 89 (1992) 7199-7202
11. Ancoli-Israel S., Klauber M.R., Gillin J.C., Campbell S.S., and Hofstetter C.R. Sleep in non-institutionalized Alzheimer's disease patients. Aging Clin. Exp. Res. 6 (1994) 451-458
12. Anderson E., and Haymaker W. Breakthroughs in hypothalamic and pituitary research. Progress in Brain Research. Integrative Hypothalamic Activity (1974), Elsevier Scientific Publishing Company, San Diego 1-60
13. Anderson C.H. Nucleolus: changes at puberty in neurons of the suprachiasmatic nucleus and the preoptic area. Exp. Neurol. 74 (1981) 780-786
14. Andy O.J., and Stephan H. The septum in the human brain. J. Comp. Neurol. 133 (1968) 383-410
15. Araujo D.M., Lapchak P.A., Robitaille Y., Gauthier S., and Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J. Neurochem. 50 (1988) 1914-1923
16. Arendt T., Bigl V., Arendt A., and Tennstedt A. Loss of neurons in the NBM in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropath. Berlin 61 (1983) 101-108
17. Arendt T., Bigl V., and Arendt A. Neuron loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob Disease. Acta Neuropath. Berlin 65 (1984) 85-88
18. Arendt T., Brückner M.K., Bigl V., and Marcova L. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease. J. Comp. Neurol. 351 (1995) 189-222
19. Argiolas A. Oxytocin stimulation of penile erection, Pharmacology, site, and mechanism of action. In: Pedersen C.A., Caldwell J.D., Jirikowski G.F., and Insell T.R. (Eds). Oxytocin in maternal, sexual, and social behaviors (1992), NY Acad. Sci., Amsterdam 194-203
20. Arisaka O., Arisaka M., Ikebe A., Niijima S., Shimura N., Hosaka A., and Yabuta K. Central diabetes insipidus in hypoxic brain damage. Child's Nerv. Syst. 8 (1992) 81-82
21. Arletti R., Benelli A., and Bertolini A. Influence of oxytocin on feeding behavior in the rat. Peptides 10 (1989) 89-93
22. Arletti R., Benelli A., and Bertolini A. Oxytocin involvement in male and female sexual behavior. In: Pedersen C.A., Caldwell J.D., Jirikowski G.F., and Insell T.R. (Eds). Oxytocin in maternal, sexual, and social behaviors (1992), NY Acad. Sci., New York 180-193
23. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., and Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1 (1991) 103-116
24. Bahnsen U., Oosting P., Swaab D.F., Nahke P., Richter D., and Schmale H. A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus. The EMBO Journal 11 (1992) 19-23
25. Bakker J., Van Ophemert J., and Slob A.K. Organization of partner preference and sexual behavior and its nocturnal rhythmicity in male rats. Behav. Neurosci. 107 (1993) 1-10
26. Bardeleben U., and Holsboer F. Corticol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression. J. Neuroendocrinol. 1 (1989) 485-488
27. Bargmann W. Über die neurosekretorische Verknüpfung von Hypothalamus und Neurohypophyse. Z. Zellforsch. 34 (1949) 610-634
28. Barry J. Neurocrinie et synapses 'neurosécrétoires'. Arch. Anat. Micr. Morph. Exp. 43 (1954) 310-320
29. Barry J. Immunofluorescence study of LRF neurons in man. Cell Tiss. Res. 181 (1977) 1-14
30. Bartanusz V., Jezova D., Bertini L.T., Tilders F.J.H., Aubry J.M., and Kiss J.Z. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132 (1993) 895-902
31. Bauer H.G. Endocrine and other clinical manifestations of hypothalamic disease. J. Clin. Endocrinol. 14 (1954) 13-31
32. Bauer H.G. Endocrine and metabolic conditions related to pathology in the hypothalamus: a review. J. Nerv. Ment. Dis. 128 (1959) 323-338
33. Bauman M.L. Microscopic neuroanatomic abnormalities in autism. Pediatrics 87 (1991) 791-796
34. Benelli A., Bertolini A., and Arletti R. Oxytocin-induced inhibition of feeding and drinking: no sexual dimorphism in rats. Neuropeptides 20 (1991) 57-62
35. Benzing W.C., and Mufson E.J. Increased number of NADPH-d-positive neurons within the substantia innominata in Alzheimer's disease. Brain Res. 670 (1995) 351-355
36. Berga S.L., Mortola J.F., and Yen S.S.C. Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 66 (1988) 242-244
37. Bergeron C., Kovacs K., Ezrin C., and Mizzen C. Hereditary diabetes insipidus: an immunohistochemical study of the hypothalamus and pituitary gland. Acta Neuropathol. 81 (1991) 345-348
38. Bernstein H.G., Järvinen M., Pöllänen R., Schirpke H., Knöfel B., and Rinne R. Cyastatin C containing neurons in human postmortem hypothalamus. Neurosci. Lett. 88 (1988) 131-134
39. Blair-Bell W. The pituitary body and action of pituitary extract in shock, uterine atony, and intestinal paresis. Brit. Med. J. 2 (1909) 1609-1613
40. Blanks J.C., Hinton D.R., Sadun A.A., and Miller C.A. Retinal ganglion cell degeneration in Alzheiner's disease. Brain Res. 501 (1989) 364-372
41. Bliwise D.L., Hughes M., McMahon P.M., and Kutner N. Observed sleep/wakefulness and severity of dementia in an Alzheimer's disease special care unit. J. Gerontol. 50A (1995) M303-M306
42. Bloch G.J., Eckersell C., and Mills R. Distribution of galanin-immunoreactive cells within sexually dimorphic components of the medial preoptic area of the male and female rat. Brain Res. 620 (1993) 259-268
43. Bloch B., Gaillard R.C., Culler M.D., and Negro-Vilar A. Immunohistochemical detection of proluteinizing hormone-releasing hormone peptides in neurons in the human hypothalamus. J. Clin. Endocrinol. Metab. 74 (1992) 135-138
44. Blouin A., Blouin J., Aubin P., Carter J., Goldstein C., Boyer H., and Perez E. Seasonal patterns of bulimia nervosa. Am. J. Psychiatry 149 (1992) 73-81
45. Boer K., Dogterom J., and Pronker H.F. Pituitary content of oxytocin, vasopressin and α-melanocyte-stimulating hormone in the fetus of the rat during labour. J. Endocrinol. 86 (1980) 221-229
46. Boersma C.J.C., and Van Leeuwen F.W. Neuron-glia interactions in the release of oxytocin and vasopressin from the rat neural lobe: the role of opioids, other neuropeptides and their receptors. Neuroscience 62 4 (1994) 1003-1020
47. Bonnefond C., Palacios J.M., Probst A., and Mengod G. Distribution of galanin mRNA containing cells and galanin receptor binding sites in human and rat hypothalamus. Eur. J. Neurosci. 2 (1990) 629-637
48. Born J., Kellner C., Uthgenannt D., Kern W., and Fehm H.L. Vasopressin regulates human sleep by reducing rapid-eye-movement sleep. Am. J. Physiol. 262 (1992) E295-E300
49. Borson-Chazot F., Jordan D., Fèvre-Montange M., Kopp N., Tourniaire J., Rouzioux J.M., Veisseire M., and Mornex R. TRH and LH-RH distribution in discrete nuclei of the human hypothalamus: evidence for a left predominance of TRH. Brain Res. 382 (1986) 433-436
50. Bos N., and Mirmiran M. Circadian rhythm in neuronal discharges of cultured suprachiasmatic nucleus. Brain Res. 511 (1990) 158-162
51. Bouras C., Magistretti P.J., and Morrison J.H. An immunohistochemical study of six biologically active peptides in the human brain. Hum. Neurobiol. 5 (1986) 213-226
52. Bouras C., Magistretti P.J., Morrison J.H., and Constantinidis J. An immunohistochemical study of prosomatostatin-derived peptides in the human brain. Neuroscience 22 3 (1987) 781-800
53. Braak H., and Braak E. The hypothalamus of the human adult: chiasmatic region. Anat. Embryol. 176 (1987) 315-330
54. Braak H., and Braak E. Cortical and subcortical argyrophylic grains characterize a disease associated with adult onset dementia. Neuropathol. Appl. Neurobiol. 15 (1989) 13-26
55. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
56. Braak H., and Braak E. Anatomy of the human hypothalamus (chiasmatic and tuberal region). In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease, Progress in Brain Research (1992), Elsevier, New York 3-16
57. Brady L.S., Whitfield Jr. H.J., Fox R.J., Gold P.W., and Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralcorticoid receptor gene expression in rat brain. J. Clin. Invest. 87 (1991) 831-837
58. Brady L.S., Gold P.W., Herkenham M., Lynn A.B., and Whitfield Jr. H.J. The antidepressants fluoxetine, idazoxan and phenylzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implication. Brain Res. 572 (1992) 117-125
59. Braverman L.E., Mancini J.P., and McGoldrick D.M. Hereditary idiopathic diabetes insipidus. A case report with autopsy findings. Ann. Intern. Med. 63 (1965) 503-508
60. Breder C.D., Dinarello C.A., and Saper C.B. Interleukin-I Immunoreactive innervation of the human hypothalamus. Science 240 (1988) 321-324
61. Bresson J.L., Clavequin M.C., Fellmann D., and Bugnon C. Human hypothalamic neuronal system revealed with a salmon-melanin-concentrating hormone (MCH) antiserum. Neurosci. Lett. 102 (1989) 39-43
62. Brockhaus H. Beitrag zur normalen Anatomie des Hypothalamus und der Zona incerta beim Menschen. J. Psychol. Neurol. 51 (1942) 96-196
63. Brooks C. The history of thought concerning the hypothalamus and its functions. Brain Res. Bull. 20 (1988) 657-667
64. Brownfield M.S., and Kozlowski G.P. The hypothalamochoroidal tract. I. Immunohistochemical demonstration of neurophysin pathways to telencephalic choroid plexuses and cerebrospinal fluid. Cell Tissue Res. 178 (1977) 111-127
65. Brzezinski A., Lynch H.J., Seibel M.M., Deng M.H., Nader T.M., and Wurtman R.J. The circadian rhythm of plasma melatonin during the normal menstrual cycle and in amenorrheic women. J. Clin. Endocrinol. Metab. 66 (1988) 891-895
66. Bugnon C., Bloch B., Lenys D., and Fellmann D. Infundibular neurons of the human hypothalamus simultaneously reactive with antisera against endorphins, ACTH, MSH and β-LPH (1979)
67. Buijs R.M., and Swaab D.F. Immuno-electron microscopical demonstration of vasopressin and oxytocin synapses in the limbic system of the rat. Cell Tissue Res. 204 (1979) 355-365
68. Buijs R.M., De Vries G.J., Van Leeuwen F.W., and Swaab D.F. Vasopressin and oxytocin: distribution and putative functions in the brain. In: Cross B.A., and Leng G.A. (Eds). The neurohypophysis: structure, function and control. Progress in Brain Research (1983), Elsevier, Amsterdam 115-122
69. Burford G.D., and Robinson I. Oxytocin, vasopressin and neurophysins in the hypothalamo-neuro-hypophysial system of the human fetus. J. Endocrinol. 95 (1982) 403-408
70. Byne W., Mattiace L., Kress Y., and Davies P. Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat. J. Comp. Neurol. 306 (1991) 602-612
71. Cairns H., Oldfield R.C., Pennybacker J.B., and Whitteridge D. Akinetic mutism with an epidermoid cyst of the 3rd ventricle. Brain 64 (1941) 273-290
72. Campbell S.S., Kripke D.F., Gillin J.C., and Hrubovcak J.C. Exposure to light in healthy elderly subjects and Alzheimer patients. Physiol. Behav. 42 (1988) 141-144
73. Candy J.M., Perry R.H., Thompson J.E., Johnson M., and Oakley A.E. Neuropeptide localisation in the substantia innominata and adjacent regions of the human brain. J. Anat. 140 2 (1985) 309-327
74. Carlsson A., Svennerholm L., and Winblad B. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychol. Scand. 61 (1980) 75-85
75. Carson M.J., Slager U.T., and Steinberg R.M. Simultaneous occurrence of diabetes mellitus, diabetes insipidus, and optic atrophy in a brother and sister. Am. J. Dis. Child. 131 (1977) 1382
76. Carter L.S. Oxytocin & Sexual Behavior. Neurosci. Biobehav. Rev. 16 (1992) 131-144
77. Cascino G.D., Andermann F., Berkovic S.F., Kuzniecky R.I., Sharbrough F.W., Keene D.L., Bladin P.F., Kelly P.J., Olivier A., and Feindel W. Gelastic seizures and hypothalamic hamartomas: evaluation of patients undergoing chronic intracranial EEG monitoring and outcome of surgical treatment. Neurology 43 (1993) 747-750
78. Catalina P.F., Rodriguez García M., De la Torre C., Páramo C., and García-Mayor R.V.G. Diabetes insipidus for five years preceding the diagnosis of hypothalamic Langerhans cell histiocytosis. J. Endocrinol. Invest. 18 (1995) 663-666
79. Chai S.Y., McKenzie J.S., McKinley M.J., and Mendelsohn F. Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography. J. Comp. Neurol. 291 (1990) 179-194
80. Chandrashekaran M.K. Circadian rhythms, menstrual cycles and time sense in humans under social isolation. In: Hirosige T., and Honma K. (Eds). Evolution of Circadian Clock (1994), Hokkaido University Press, Sapporo, Japan 263-274
81. Chan-Palay V.L. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of Galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 273 (1988) 543-557
82. Chan-Palay V.L. Neurons with Galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist. Brain Res. Bull. 21 (1988) 465-472
83. Chan-Palay V.L., and Jentsch B. Galinin tuberomamillary neurons in the hypothalamus in Alzheimer's and Parkinson's disease. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease. Progress in Brain Research (1992), Elsevier 263-270
84. Chard T., Hudson C.N., Edwards C.R.W., and Boyd N.R.H. Release of oxytocin and vasopressin by the human foetus during labour. Nature 234 (1971) 352-353
85. Charness M.E., and DeLaPaz R.L. Mamillary body atrophy in Wernicke's encephalopathy: Antemortem identification using magnetic resonance imaging. Ann. Neurol. 22 (1987) 595-600
86. Chui H.C., Bondareff W., Zarrow C., and Slager U. Stability of neuronal number in the human nucleus basalis of Meynert with aging. Neurobiol. Aging 5 (1984) 83-88
87. Ciofi P., Tramu G., and Bloch B. Comparative immunohistochemical study of the distribution of neuropeptide Y, growth hormone-releasing factor and the carboxyterminus of precursor protein GHRF in the human hypothalamic infundibular area. Neuroendocrinology 51 (1990) 429-436
88. Ciofi P., Croix D., and Tramu G. Colocalization of GHRF and NPY immunoreactivities in neurons of the infundibular area of the human brain. Neuroendocrinology 47 (1988) 469-472
89. Clattenburg R.E., Singh R.P., and Montemurro D.G. Postcoital ultrastructural changes in neurons of the suprachiasmatic nucleus of the rabbit. Z. Zellforsch. 125 (1972) 448-459
90. Cohen R.A., and Albers H.E. Disruption of human circadian and cognitive regulation following a discrete hypothalamic lesion: a case study. Neurology 41 (1991) 726-729
91. Coleman P.D., and Flood D. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging 8 (1986) 521-545
92. Collado P., Beyer C., Hutchison J.B., and Holman S.D. Hypothalamic distribution of astrocytes is genderrelated in Mongolian gerbils. Neurosci. Lett. 184 (1995) 86-89
93. Corder R., Pralong F.P., Muller A.F., and Gaillard R.C. Regional distribution of neuropeptide Y-like immunoreactivity in human hypothalamus measured by immunoradiometric assay: possible influence of chronic respiratory failure on tissue levels. Neuroendocrinology 51 (1990) 23-30
94. Cortés R., Probst A., and Palacios J.M. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: forebrain. Neuroscience 20 (1987) 65-107
95. Cremers C.W.R.J., Wijdeveld P., and Pinckers A. Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome): a review of 88 cases from the literature with personal observations on 3 new patients. Acta Paed. Scand. (Suppl.) 264 (1977) 3-16
96. MacMillan, NY. Crosby E.C., Humphrey T., and Lauer E.W. Correlative Anatomy of the Nervous System (1962) 310
97. Cullen K.M., and Halliday G.M. Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics. Metab. Brain Dis. 10 (1995) 81-91
98. Curcio C.A., and Drucker D.N. Retinal ganglion cells in Alzheimer's disease and aging. Ann. Neurol. 33 (1993) 248-257
99. Cushing H. The pituitary body and hypothalamus (1929), Charles C. Thomas, Amsterdam
100. Cusimano G., Capriani C.G., Bonifato V., and Meco G. Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients. Acta Neurol. Scand. 83 (1991) 145-150
101. Czeisler C.A., Shanahan T.L., Klerman E.B., Martens H., Brotman D.J., Emens J.S., Klein T., and Rizzo J.F. Suppression of melatonin secretion in some blind patients by exposure to bright light. New Engl. J. Med. 332 (1995) 6-11
102. Daniel P.M., and Prichard M.M.L. The human hypothalamus and pituitary stalk after hypophysectomy or pituitary stalk section. Brain 95 (1972) 813-824
103. Daniel P.M., and Prichard M.M.L. Studies of the hypothalamus and the pituitary gland. With special reference to the effects of transection of the pituitary stalk. Acta Endocrinol. (Suppl.) 201 (1975) 1-216
104. Daniel S.S., Stark R.I., Zubrow A.B., Fox H.E., Husain M.K., and James L.S. Factors in the release of vasopressin by the hypoxic fetus. Endocrinology 113 (1983) 1623-1628
105. Davies D.C., McCoubrie P., McDonald B., and Jobst K.A. Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease. Br. J. Ophthalmol. 79 (1995) 596-600
106. De Bellis A., Bizzarro A., Amoressano Paglionico S., Di Martino S., Criscuolo T., Sinisi A., Lombardi G., and Bellastella A. Detection of vasopressin cell antibodies in some patients with autoimmune endocrine disease without overt diabetes insipidus. Clin. Endocrinol. 40 (1994) 173-177
107. De Goeij D., Kvetnansky R., Whitnall M.H., Jezova D., Berkenbosch F., and Tilders F.J.H. Repeated stress induced activation of corticotropin-releasing factor (CRF) neurons enhances vasopressin stores and colocalization with CRF in the median eminence of rats. Neuroendocrinology 53 (1991) 150-159
108. De Goeij D., Dijkstra H., and Tilders F.J.H. Chronic psychosocial stress enhances vasopressin but not corticotropin-releasing factor in the external zone of the median eminence of male rats: relationship to subordinate status. Endocrinology 131 (1992) 247-253
109. De Goeij D., Binnekade E., and Tilders F.J.H. Chronic intermittent stress enhances vasopressin but not corticotropin-releasing factor secretion during hypoglycemia. Am. J. Physiol. 263 (1992) E394-E399
110. De Goeij D., Jezova D., and Tilders F.J.H. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res. 577 (1992) 165-168
111. De Jonge F.H., Louwerse A.L., Ooms M.P., Evers P., Endert E., and Van de Poll N.E. Lesions of the SDNPOA inhibit sexual behaviour of male Wistar rats. Brain Res. Bull. 23 (1989) 483-492
112. De Reuck J., Decoo D., Van Aken J., Strijckmans K., Lemahieu I., and Vermeulen A. Positron emission tomography study of the human hypothalamus during normal ageing in ischemic and degenerative disorders. Clin. Neurol. Neurosurg. 94 (1992) 113-118
113. De Vries G.J., Buijs R.M., and Swaab D.F. Ontogeny of the vasopressinergic neurons of the suprachiasmatic nucleus and their extrahypothalamic projections in the rat brain - presence of a sex difference in the lateral septum. Brain Res. 218 (1981) 67-78
114. De Vries G.J., and Buijs R.M. The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum. Brain Res. 273 (1983) 307-317
115. De Wied D., and Van Ree I.M. Neuropeptides, mental performance and aging. Life Sci. 31 (1982) 709-719
116. Delbende C., Contesse V., Mocaër E., Kamoun A., and Vaudry H. The novel antidepressant tianeptine reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis. Eur. J. Pharmacol. 202 (1991) 391-392
117. Den Hartog Jager W.A., and Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J. Neurol. Neurosurg. Psychiatry 23 (1960) 283
118. Désy L., and Pelletier G. Immunohistochemical localization of alpha-melanocyte stimulating hormone (α-MSH) in the human hypothalamus. Brain Res. 154 (1978) 377-381
119. Dieckmann G., Schneider-Jonietz B., and Schneider H. Psychiatric and neuropsychological findings after stereotactic hypothalamotomy, in cases of extreme sexual aggressivity. Acta Neurochir. 44 (1988) 163-166
120. Diepen R. Der Hypothalamus. In: Bargmann W. (Ed). Handbuch der mikroskopische Anatomie des Menschen IV/7 (1962), Springer, Springfield, IL 1-181
121. Dierickx K., and Vandesande F. Immunocytochemical localization of the vasopressinergic and the oxytocinergic neurons in the human hypothalamus. Cell Tissue Res. 184 (1977) 15-27
122. Dierickx K., and Vandesande F. Immunocytochemical demonstration of separate vasopressin-neurophysin and oxytocin-neurophysin neurons in the human hypothalamus. Cell Tissue Res. 196 (1979) 203-212
123. Dörner G., and Staudt J. Vergleichende morphologische Untersuchungen der Hypothalamusdifferenzierung bei Ratte und Mensch. Endokrinologie 59 (1972) S152-S155
124. Dörner G. Neuroendocrine response to estrogen and brain differentiation in heterosexuals, homosexuals, and transsexuals. Arch. Sexual Behav. 17 (1988) 57-75
125. Ducsay C.A. Rhythms and parturition. Endocrinologist 6 (1996) 37-43
126. Endo T. Morning bright light effects on circadian rhythms and sleep structure of SAD. Jikeikai Med. J. 40 (1993) 295-307
127. Erkut Z.A., Hofman M.A., Ravid R., and Swaab D.F. Increased activity of hypothalamic corticotropinreleasing hormone neurons in multiple sclerosis. J. Neuroimmunol. 62 (1995) 27-33
128. Etienne P., Robitailli Y., Wood P., Gauthier S., Nair N.P.V., and Quirain R. Nucleus basalis neuronal loss, neuritic plaque and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 19 (1986) 1279-1291
129. Evans D., Van der Kleij A., Sonnemans M., Burbach J.P.H., and Van Leeuwen F.W. Frameshift mutations at two hotspots in vasopressin transcripts in post-mitotic neurons. Proc. Natl. Acad. Sci. USA 91 (1994) 6059-6063
130. Evans D., Burbach J.P.H., Swaab D.F., and Van Leeuwen F.W. Mutant vasopressin precursors in the human hypothalamus: evidence for neuronal somatic mutations in man. Neuroscience 71 (1996) 1025-1030
131. Fajardo B., Browning M., Fisher D., and Paton J. Effect of nursery environment of state regulation in very-low-birth-weight premature infants. Infant Behav. Dev. 13 (1990) 287-303
132. Fallon J.H., Loughlin S.E., and Ribak C.E. The islands of Calleja complex of rat basal forebrain. III. Histochemical evidence for a striatopallidal system. J. Comp. Neurol. 218 (1983) 91-120
133. Farini A. Diabete insipide ed opoterapia ipofisaria. Gaz. Osp. Clin. 34 (1913) 1135-1139
134. Fellmann D., Bloch B., Bugnon C., and Lenys D. Etude immunocytologique de la maturation des axes neuroglandulaires hypothalamo-neurohypophysaires chez le foetus humain. J. Physiol. Paris 75 (1979) 37-43
135. Feremutsch K. Die Variabilität der cytoarchitektonischen Struktur des menschlichen Hypothalamus. Monatschr. Psychiatr. Neurol. 116 (1948) 257-283
136. Fischer P., Simanyi M., and Danielczyk W. Depression in dementia of the Alzheimer type and in multiinfarct dementia. Am. J. Psychiatry 147 (1990) 1484-1487
137. Fliers E., and Swaab D.F. Activation of vasopressinergic and oxytocinergic neurons during aging in the Wistar rat. Peptides 4 (1983) 165-170
138. Fliers E., Swaab D.F., Pool C.W., and Verwer R.W.H. The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus: Changes with aging and in senile dementia. Brain Res. 342 (1985) 45-53
139. Fliers E., Guldenaar S., Van de Wal N., and Swaab D.F. Extrahypothalamic vasopressin and oxytocin in the human brain; presence of vasopressin cells in the bed nucleus of the stria terminalis. Brain Res. 375 (1986) 363-367
140. Fliers E., Noppen N., Wiersinga W.M., Visser T.J., and Swaab D.F. Distribution of thyrotropinreleasing hormone (TRH)-containing cells and fibers in the human hypothalamus. J. Comp. Neurol. 348 (1994) 1-13
141. Fodor M., Mörcs T.J., and Palkovits M. Immunohistochemical study on the distribution of neuropeptides within the pontine tegmentum - particularly the parabrachial nuclei and the locus coeruleus of the human brain. Neuroscience 46 (1992) 891-908
142. Friedmann A.S., Malott K.A., Memoli V.A., Pai S.I., Yu X.-M., and North W.G. Products of vasopressin gene expression in small-cell carcinoma of the lung. Br. J. Cancer 69 (1994) 260-263
143. Frolkis V.V., Golovcheko S.F., Medved V.I., and Frolkis R.A. Vasopressin and cardiovascular system in aging. Gerontology 28 (1982) 290-302
144. Gabreëls B., Swaab D.F., Seidah N.G., Van Duijnhoven H.L.P., Martens G.J.M., and Van Leeuwen F.W. Differential expression of the neuroendocrine polypeptide 7B2 in hypothalami of Prader-(Labhart)-Willi syndrome patients. Brain Res. 657 (1994) 281-293
145. Gai W.P., Geffen L.B., and Blessing W.W. Galanin immunoreactive neurons in the human hypothalamus: colocalization with vasopressin-containing neurons. J. Comp. Neurol. 298 (1990) 265-280
146. Gallerani M., Manfredini R., Cocurullo A., Goldoni C., Bigoni M., and Fersini C. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol. Scand. 87 (1993) 482-487
147. German D.C., Bruce G., and Hersh L.B. Immunohistochemical staining of cholinergic neurons in the human brain using a polyclonal antibody to human choline acetyltransferase. Neurosci. Lett. 61 (1985) 1-5
148. Gillies G.E., Linton E.A., and Lowry P.J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299 (1982) 355-357
149. Gladue B.A., Green R., and Helleman R.E. Neuroendocrine response to estrogen and sexual orientation. Science 225 (1984) 1496-1499
150. Gold. Hypothalamic obesity: the myth of the ventromedial nucleus. Science 182 (1973) 488-490
151. Gorski R.A., Gordon J.H., Shryne J.E., and Southam A.M. Evidence for a morphological sex difference within the medial preoptic area of the rat
152. Goudsmit E., Fliers E., and Swaab D.F. Vasopressin and oxytocin excretion in the Brown Norway rat in relation to aging, water metabolism and testosterone. Mech. Ageing Dev. 44 (1988) 241-252
153. Goudsmit E., Hofman M.A., Fliers E., and Swaab D.F. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease. Neurobiol. Aging 11 (1990) 529-536
154. Goudsmit E., Neijmeijer-Leloux A., and Swaab D.F. The human hypothalamo-neurohypophyseal system in relation to development, aging and Alzheimer's disease. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease. Progress in Brain Research (1992), Elsevier, Berlin 237-248
155. Guldenaar S., and Swaab D.F. Estimation of oxytocin mRNA in the human paraventricular nucleus in AIDS by means of quantitative in situ hybridization. Brain Res. 700 (1995) 107-114
156. Güldner F.-H. Sexual dimorphisms of axo-spine synapses and postsynaptic density material in the suprachiasmatic nucleus of the rat. Neurosci. Lett. 28 (1982) 145-150
157. Güldner F.-H. Numbers of neurons and astroglial cells in the suprachiasmatic nucleus of male and female rats. Exp. Brain Res. 50 (1983) 373-376
158. Harding A.J., Ng J.L.F., Halliday G.M., and Oliver J. Comparison of the number of vasopressin-producing hypothalamic neurons in rats and humans. J. Neuroendocrinol. 7 (1995) 629-636
159. Harding A.J., Halliday G.M., Ng J.L.F., Harper C.G., and Kril J.J. Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent. Neuroscience 72 (1996) 699-708
160. Hart M. Hypertrophy of human subventricular hypothalamic nucleus in starvation. Arch. Pathol. 91 (1971) 493-496
161. Haugh R.M., and Markesbery W.R. Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function. Arch. Neurol. 40 (1983) 560-563
162. Hedreen J., Struble R.G., Whitehouse P.J., and Price D.L. Topography of the magnocellular basal forebrain system in human brain. J. Neuropath. Exp. Neurol. 43 (1984) 1-21
163. Hefti F., Hartikka J., Salvatierra A., Weiner W.J., and Mash D.C. Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neurosci. Lett. 69 (1986) 37-41
164. Herzberg N.H., Goudsmit E., Kruisbrink J., and Boer G.J. Testosterone treatment restores reduced vasopressin-binding sites in the kidney of the ageing rat. J. Endocrinol. 123 (1989) 59-63
165. Hinton D.R., Sadun A.A., Blanks J.C., and Miller C.A. Optic nerve degeneration in Alzheimer's disease. N. Engl. J. Med. 315 (1986) 485-487
166. His W. Vorschläge zur Einteilung des Gehirns. Arch. Anat. Entwickl. Gesch. (Leipzig) 17 (1893) 172-179
167. Hofman M.A., and Swaab D.F. The sexually dimorphic nucleus of the preoptic area in the human brain: a comparative morphometric study. J. Anat. 164 (1989) 55-72
168. Hofman M.A., and Swaab D.F. The human hypothalamus: comparative morphometry and photoperiodic influences. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease. Progress in Brain Research (1992), Elsevier, Amsterdam 133-149
169. Hofman M.A., and Swaab D.F. Seasonal changes in the suprachiasmatic nucleus of man. Neurosci. Lett. 139 (1992) 257-260
170. Hofman M.A., Purba J.S., and Swaab D.F. Annual variations in the vasopressin neuron population of the human suprachiasmatic nucleus. Neuroscience 53 (1993) 1103-1112
171. Hofman M.A., and Swaab D.F. Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J. Biol. Rhythms 8 4 (1993) 283-295
172. Hofman M.A., and Swaab D.F. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 651 (1994) 134-142
173. Hofman M.A., and Swaab D.F. Influence of aging on the seasonal rhythm of the human suprachiasmatic nucleus (SCN). Neurobiol. Aging 16 (1995) 965-971
174. Hofman M.A., Skene D.J., and Swaab D.F. Effect of photoperiod on the diurnal melatonin and 5-methoxytryptophol rhythms in the human pineal gland. Brain Res. 671 (1995) 254-260
175. Hofman M.A., Zhou J.N., and Swaab D.F. Suprachiasmatic nucleus of the human brain: an immunocytochemical and morphometric analysis. Anat. Rec. 244 (1996) 552-562
176. Holman S.D., and Hutchison J.B. Differential effects of neonatal castration on the development of sexually dimorphic brain areas in the gerbil. Dev. Brain Res. 61 (1991) 147-150
177. Holsboer F., Spengler D., and Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease. Progress in Brain Research (1992), Elsevier, Amsterdam 385-417
178. Holtzman E.J., Harris H.W., Kolakowski L.F., Guay-Woodford L.M., Botelho B., and Ausiello D.A. A molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. New Engl. J. Med. 328 (1993) 1534-1537
179. Honma K., Honma S., Kohsaka M., and Fukuda N. Seasonality in human circadian rhythms: sleep, body temperature and plasma melatonin rhythms. In: Hiroshige T., and Honma K. (Eds). Circadian Clocks from Cell to Human (1992), Hokkaido Univ. Press, Amsterdam 97-116
180. Honnebier W.J., and Swaab D.F. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. J. Obstet. Gynaecol. Brit. Cwlth 80 (1973) 577-588
181. Honnebier M., Swaab D.F., and Mirmiran M. Diurnal rhythmicity during early human development. In: Reppert S.M. (Ed). Development of Circadian Rhythmicity and photoperiodism in Mammals (1989), Perinatology Pres, Sapporo 83-103
182. 8 oxytocin on spontaneous nocturnal myometrial contractions. J. Dev. Physiol. 12 (1989) 225-232
183. Hoogendijk J.E., Fliers E., Swaab D.F., and Verwer R.W.H. Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia. J. Neurol. Sci. 69 (1985) 291-299
184. Horn E., Lach B., Lapierre Y., and Hrdina P. Hypothalamic pathology in the neuroleptic malignant syndrome. Am. J. Psychiatry 145 (1988) 617-620
185. Hozumi S., Okawa M., Mishima K., Hishikawa Y., Hori H., and Takahashi K. Phototherapy for elderly patients with dementia and sleep-wake rhythm disorders - a comparison between morning and evening light exposure. Japn, J. Psych. Neurol. 44 (1990) 813-814
186. Hughes A.M., Everitt B.J., Lightman S.L., and Todd K. Oxytocin in the central nervous system and sexual behavior in male rats. Brain Res. 414 (1987) 133-137
187. Insel T.R. Oxytocin - a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic, and comparative studies. Psychoneuroendocrinology 17 (1992) 3-35
188. Iraizoz I., De Lacalle S., and Gonzalo M. Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert. Neuroscience 14 (1991) 33-40
189. Ishii T. Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol. 6 (1966) 181-187
190. Ito M., Mori Y., Oiso Y., and Saito H. A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus. J. Clin. Invest. 87 (1991) 725-728
191. Itoh N., Obata K., Yanaihara N., and Okamoto H. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27. Nature 304 (1983) 547-549
192. Iwamoto H.S., Rudolph A.M., Keil L.C., and Heymann M.A. Hemodynamic responses of the sheep fetus to vasopressin infusion. Circ. Res. 44 (1979) 430-436
193. Jacobson C.D., Shryne J.E., Shapiro F., and Gorski R.A. Ontogeny of the sexually dimorphic nucleus of the preoptic area. J. Comp. Neurol. 193 (1980) 541-548
194. Johnson A.E., Coirini H., Insel T., and McEwen B.S. The regulation of oxytocin receptor binding in the ventromedial hypothalamic nucleus by testosterone and its metabolites. Endocrinology 128 (1991) 891-896
195. Jones E., Burton H., Saper C.B., and Swanson L.W. Midbrain, diencephalic and cortical relationships of the basal nucleus of Meynert and associated structures in primates. J. Comp. Neurol. 167 (1976) 385-420
196. Jongkind J.F., and Swaab D.F. The distribution of thiamine diphosphate-phosphohydrose in the neurosecretory nuclei of the rat following osmotic stress. Histochemie 11 (1967) 319-324
197. Kaplan A.S., and Garfinkel P.E. The neuroendocrinology of anorexia nervosa. In: Collu R., Brown G.M., and Van Loon G.R. (Eds). Clinical Neuroendocrinology (1988), Blackwell Scientific Publications, Ithaca, NY 105-122
198. Katz B., Rimmer S., Iragui V., and Katzman R. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?. Ann. Neurol. 26 (1989) 221-225
199. Khan-Dawood F.S., and Dawood M.Y. Oxytocin content of human fetal pituitary glands. Am. J. Obstet. Gynecol. 148 (1984) 420-422
200. Kopp N., Najimi M., Champier J., Chigr F., Charnay Y., Epelbaum J., and Jordan D. Ontogeny of peptides in human hypothalamus in relation to sudden infant death syndrome (SIDS). In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease, Progress in Brain Research (1992), Elsevier, Boston, USA 167-188
201. Kordower J.H., Gash D.M., Bothwell M., Hersh L., and Mufson E.J. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (CH4) of Alzheimer's patients. Neurobiol. Aging 10 (1989) 67-74
202. Korting C., Van Zwieten E.J., Boer G.J., Ravid R., and Swaab D.F. Increase in vasopressin binding sites in the human choroid plexus in Alzheimer's disease. Brain Res. 706 (1995) 151-154
203. Kovacs K., and Sheehan H.L. Pituitary changes in Kallman's syndrome. A histologic, immunocytologic, ultrastructural, and immunoelectron microscopic study. Fert. Steril. 37 (1982) 83-89
204. Kremer H.P.H., Roos R., Dingjan G., et al. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J. Neuropathol. Exp. Neurol. 49 (1990) 371-382
205. Kremer H.P.H., Swaab D.F., Bots G., Fisser B., Ravid R., and Roos R. The hypothalamic lateral tuberal nucleus in Alzheimer's disease. Ann. Neurol. 29 (1991) 279-284
206. Kremer H.P.H. The hypothalamic lateral tuberal nucleus: normal anatomy and changes in neurological diseases. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease, Progress in Brain Research (1992), Elsevier, Amsterdam 249-261
207. Kremer H.P.H., and Bots G. Lewy bodies in the lateral hypothalamus: do they imply neuronal loss?. Movement Disorders 8 3 (1993) 315-320
208. Kremer H.P.H., Tallaksen-Greene S.J., and Albin R.L. AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease. Neurology 43 (1993) 1593-1595
209. Kripke D.F. Therapeutic effects of bright light in depressed patients. In: Wurtman R.J., Baum M.J., and Potts Jr. J.T. (Eds). The Medical and Biological Effects of Light (1985), Ann. NY Acad. Sci., Amsterdam 270-281
210. Laemle L.K. Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in the suprachiasmatic nucleus of the perinatal rat. Dev. Brain Res. 41 (1988) 308-312
211. Laing R.B.S., Dean J.C.S., Pearson D.W.M., and Johnston A.W. Facial dysmorphism: a marker of autosomal dominant cranial diabetes insipidus. J. Med. Genet. 28 (1991) 544-546
212. Lakhdar-Ghazal N., Kalsbeek A., and Pévet P. Sexual dimorphism and seasonal variations in vasoactive intestinal peptide immunoreactivity in the suprachiasmatic nucleus of jerboa (Jaculus orientalis). Neurosci. Lett. 144 (1992) 29-33
213. Lam R.W., Goldner E.M., Solyom L., and Remick R.A. A controlled study of light therapy for bulimia nervosa. Am. J. Psychiatry 151 5 (1994) 744-750
214. Langston J.W., and Forno L.S. The hypothalamus in Parkinson disease. Ann. Neurol. 3 (1978) 129-133
215. Lantos T.A., Görcs T.J., and Palkovits M. Immunohistochemical mapping of neuropeptides in the premamillary region of the hypothalamus in rats. Brain Res. Rev. 20 (1995) 209-249
216. Lebert F., Pasquier F., and Petit H. Sundowning syndrome in demented patients without neuroleptic therapy. Arch. Gerontol. Geriatr. 22 (1996) 49-54
217. Legros J.J., and Geenen V. Neurophysins in central diabetes insipidus. Horm. Res. 45 (1996) 182-186
218. Le Gros Clark W.E. Morphological aspects of the hypothalamus. In: Le Gros Clark W.E., Beattie J., Riddoch G., and Dott N.M. (Eds). The Hypothalamus. Morphological, Functional, Clinical and Surgical Aspects (1938), Oliver and Boyd, New York 1-68
219. Legros J.J., Gilot P., Schmitz S., Bruwier M., Mantanus H., and Timsit-Berthier M. Neurohypophyseal peptides and cognitive function: a clinical approach. In: Brambilla F., Racagni G., and De Wied D. (Eds). Progress in Psychoneuroendocrinology (1980), Elsevier Science Publishers, Edinburgh 325-337
220. Legros J.J., and Anseau M. Neurohypophyseal peptides and psychopathology. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). Progress in Brain Research (1992), Elsevier, Amsterdam
221. Leibowitz S.F., Hammer N.J., and Chang K. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol. Behav. 27 (1981) 1031-1040
222. Lesch A., and Bogerts B. The diencephalon in schizophrenia: evidence for reduced thickness of the periventricular grey matter. Eur. Arch. Psychiatr. Neurol. Sci. 234 (1984) 212-219
223. Lesur A., Gaspar P., Alvarez C., and Berger B. Chemoanatomic compartments in the human bed nucleus of the stria terminalis. Neuroscience 32 1 (1989) 181-194
224. LeVay S. A difference in hypothalamic structure between heterosexual and homosexual men. Science 253 (1991) 1034-1037
225. Lewin L., Mattingly D., and Millis R.R. Anorexia nervosa associated with hypothalamic tumour. Br. Med. J. 2 (1972) 629-630
226. Li Y.W., Halliday G.M., Joh T.H., Geffen L.B., and Blessing W.W. Tyrosine-hydroxylase-containing neurons in the supraoptic and paraventricular nuclei of the adult human. Brain Res. 461 (1988) 75-86
227. Lingjaerde O., Reichborn-Kjennerud T., Haggag A., Gärtner I., Berg E.M., and Narud K. Treatment of winter depression in Norway. I: short- and long-term effects of 1500-lux white light for 6 days. Acta Psych. Scand. 88 (1993) 292-299
228. Loup F., Tribollet E., Dubois-Dauphin M., and Dreifuss J.J. Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res. 555 (1991) 220-232
229. Lowes-Hommel P., Gertz J.Z., Ferszt R., and Cerros-Navarro J. The basal nucleus of Meynert revised, the nerve cell number decreases with age. Arch. Geront. Geriatr. 8 (1989) 21-27
230. Lucassen P.J., Ravid R., Gonatas N.K., and Swaab D.F. Activation of the human supraoptic and paraventricular neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus. Brain Res. 632 (1993) 10-23
231. Lucassen P.J., Salehi A., Pool C.W., Gonatas N.K., and Swaab D.F. Activation of vasopressin neurons in aging and Alzheimer's disease. J. Neuroendocrinol. 6 (1994) 673-679
232. Lucassen P.J., Goudsmit E., Mengod G., Palacios J.M., Raadsheer F.C., Guldenaar S., and Swaab D.F. In situ hybridization for vasopressin mRNA in the human supraoptic and paraventricular nucleus; quantitative aspects of formalin-fixed, paraffin-embedded tissue section as compared to cryostat sections. Neurosci. Meth. 57 (1995) 221-230
233. Maes M., Cosyns P., Meltzer H.Y., De Meyer F., and Peeters D. Seasonality in violent suicide but not in nonviolent suicide or homicide. Am. J. Psychiatry 150 (1993) 1380-1385
234. Mai J.K., Stephens P.H., Hopf A., and Cuello A.C. Substance P in the human brain. Neuroscience 17 3 (1986) 709-739
235. Mai J.K., Kedziora O., Teckhaus L., and Sofroniew M.V. Evidence for subdivisions in the human suprachiasmatic nucleus. J. Comp. Neurol. 305 (1991) 508-525
236. Mai J.K., Berger K., and Sofroniew M.V. Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. J. Hirnforsch. 34 (1993) 133-154
237. Mann D., Yates P.O., and Marcyniuk B. Alzheimer's presenile dementia, senile dementia of the Alzheimer type and Down's syndrome in middle age from an age-related continuum of pathological changes. Neuropath. Appl. Neurobiol. 10 (1984) 185-207
238. Mann N.P., Haddow R., Stokes L., Goodley S., and Rutter N. Effect of night and day on preterm infants in a newborn nursery: randomised trial. Br. Med. J. 293 (1986) 1265-1267
239. Martin J.B., and Riskind P.N. Neurologic manifestations of hypothalamic disease. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease. Progress in Brain Research (1992), Elsevier, Amsterdam 31-44
240. Martin J.P. Fits of laughter (sham mirth) in organic cerebral disease. Brain 73 (1950) 453-464
241. Martin L.J., Powers R.E., Dellovade T.L., and Price D.L. The bed nucleus-amygdala continuum in human and monkey. J. Comp. Neurol. 309 (1991) 445-485
242. Matsuda S., Sone T., Doi T., and Kahyo H. Seasonality of mean birth weight and mean gestational period in Japn. Hum. Biol. 65 3 (1993) 481-501
243. Matsumoto A., and Arai Y. Sex difference in volume of the ventromedial nucleus of the hypothalamus in the rat. Endocr. Jap. 30 (1983) 277-280
244. Matzuk M.M., and Saper C.B. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease. Ann. Neurol. 18 (1985) 552-555
245. Mazurek M.F., Beal M.F., Bird E.D., and Martin J.B. Oxytocin in Alzheimer's disease: postmortem brain levels. Neurology 37 (1987) 1001-1003
246. McLeod J.F., Kovács L., Gaskill M.B., Rittig S., Bradley G.S., and Robertson G.L. Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation. J. Clin. Endocrinol. Metab. 77 (1993) 599A-599G
247. McDuff T., and Sumi S.M. Subcortical degeneration in Alzheimer's disease. Neurology 35 (1985) 123-126
248. McGeer P.L., McGeer E.G., Suzuki J., Dolman C.E., and Nagai T. Aging, Alzheimer's disease and the cholinergic system of the basal forebrain. Neurology 34 (1984) 741-745
249. McKinley M.J., Allen A.M., Clevers J., Paxinos G., and Mendelsohn F. Angiotensin receptor binding in human hypothalamus: autoradiographic localization. Brain Res. 420 (1987) 375-379
250. Mengod G., Rigo M., Savasta M., Probst A., and Palacios J.M. Regional distribution of neuropeptide somatostatin gene expression in the human brain. Synapse 12 (1992) 62-74
251. Mesulam M.M., Musfan E.J., Levey A.I., and Wainer B.H. Atlas of cholinergic neurons in the forebrain and brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinerase histochemistry. Neuroscience 12 (1984) 669-689
252. Meyer G., Gonzalez-Hernandez T., Carrillo-Padilla F., and Ferres-Torres R. Aggregations of granule cells in the basal forebrain (islands of Calleja): Golgi and cytoarchitectonic study in different mammals, including man. J. Comp. Neurol. 284 (1989) 405-428
253. Mezey E., Kiss J.Z., Skirboll L.R., Goldstein M., and Axelrod J. Increase of corticotropin releasing factor staining in the rat paraventricular nucleus staining by depletion of hypothalamic adrenaline. Nature 310 (1984) 140-141
254. Mirmiran M., Overdijk J., Witting W., Klop A., and Swaab D.F. A simple method for recording and analyzing circadian rhythms in man. J. Neurosci. Meth. 25 (1988) 209-214
255. Mirmiran M., Kok J.H., Boer K., and Wolf H. Perinatal development of human circadian rhythms: role of the foetal biological clock. Neurosci. Biobehav. Rev. 16 (1992) 371-378
256. Mirmiran M., Kok J.H., De Kleine M.J.K., Koppe J.D., Overdijk J., and Witting W. Circadian rhythms in preterm infants: a preliminary study. Early Hum. Dev. 23 (1990) 139-146
257. Mirmiran M., and Kok J.H. Circadian rhythms in early human development. Early Hum. Dev. 26 (1991) 121-128
258. Mishima K., Okawa M., Hishikawa Y., Hozumi S., Hori H., and Takahashi K. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr. Scand. 89 (1994) 1-7
259. Modestin J., Ammann R., and Würmle O. Season of birth: comparison of patients with schizophrenia, affective disorders and alcoholism. Acta Psychiatr. Scand. 91 (1995) 140-143
260. Moe K.E., Vitiello M.V., Larsen L.H., and Prinz P.N. Sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J. Sleep Res. 4 (1995) 15-20
261. Moore R.Y. The geniculohypothalamic tract in monkey and man. Brain Res. 486 (1989) 190-194
262. Moore R.Y. The organization of the human circadian timing system. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease, Progress in Brain Research (1992), Elsevier, Amsterdam 99-117
263. Moore R.Y., and Speh J.C. A putative retinohypothalamic projection containing substance P in the human. Brain Res. 659 (1994) 249-253
264. Moore R.Y., Speh J.C., and Card J.P. The retinohypothalamic tract originates from a distinct subset of retinal ganglion cells. J. Comp. Neurol. 352 (1995) 351-366
265. Morel F. La massa intermedia ou commissure grise. Acta Anat. 4 (1947) 203-207
266. Morgan L.O. The nuclei of the region of the tuber cinereum. Arch. Neurol. Psych. 24 (1930) 267-299
267. Morgan L.O., and Gregory H.S. Pathological changes in the tuber cinereum in a group of psychoses. J. Nerv. Ment. Dis. 82 (1935) 286-298
268. Morgan L.O. Alterations in the hypothalamus in mental deficiency. Psychosom. Med. 1 (1939) 496-507
269. In: Morgane P.J., and Panksepp J. (Eds). Anatomy of the Hypothalamus. Handbook of the Hypothalamus Vol. 1 (1979), Marcel Dekker, Inc., Amsterdam
270. Morton A. A quantitative analysis of the normal neuron population of the hypothalamic magnocellular nuclei in man and of their projections to the neurophypophysis. J. Comp. Neurol. 136 (1961) 143-158
271. Monk T.M., Buysse D.J., Reynolds III C.F., Kupfer D.J., and Houck P.R. Circadian temperature rhythms of older people. Exp. Gerontol. 30 (1995) 455-474
272. Mufson E.J., Benoit R., and Mesulam M.M. Immunohistochemical evidence for a possible somatostatin-containing amygdalostriatal pathway in normal and Alzheimer's disease brain. Brain Res. 453 (1988) 117-128
273. Mufson E.J., Conner J.M., and Kordower J.H. Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis. Neuro Report 6 (1995) 1063-1066
274. Müller D., Roeder F., and Orthner H. Further results of stereotaxis in the human hypothalamus in sexual deviations. First use of this operation in addiction to drugs. Neurochirurgia 16 (1973) 113-126
275. Muragaki Y., Timothy N., Leight S., Hempstead B., Chao M.V., Trojanowski J.Q., and Lee V.-Y. Expression of trk receptors in the developing and adult human central and peripheral nervous system. J. Comp. Neurol. 356 (1995) 387-397
276. Murayama K., Meeker R.B., Murayama S., and Greenwood R.S. Developmental expression of vasopressin in the human hypothalamus: double-labeling with in situ hybridization and immunocytochemistry. Pediatr. Res. 33 (1993) 152-158
277. Murphy M.R., Seckl J.R., Burton S., Checkley S.A., and Lightman S.L. Changes in oxytocin and vasopressin secretion during sexual activity in men. J. Clin. Endocrin. Metab. 65 (1987) 738-741
278. Murphy G.M., Greenberg B.D., Ellis W.G., Forno L.S., Salamat S.M., Gonzalez-DeWhitt P.A., Lowery D.E., Tinklenberg J.R., and Eng L.F. Alzheimer's disease: β-amyloid precursor protein expression in the nucleus basalis of Meynert. Am. J. Pathol. 141 2 (1992) 357-361
279. Myers B.L., and Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci. Biobehav. Rev. 19 (1995) 553-571
280. Nagai R., McGeer P.L., Peng J.H., McGeer E.G., and Dolman C.E. Choline acetyltransferase immunohisto-chemistry in brains of Alzheimer's disease patients and controls. Neurosci. Lett. 36 (1983) 195-199
281. Nagai L., Li C.H., Hsieh S.M., Kizaki T., and Urano Y. Two cases of hereditary diabetes insipidus, with an autopsy finding in one. Acta Endocrinol. 105 (1984) 318-323
282. Nagasaki H., Ito M., Yuasa H., Saito H., Fukase M., Hamada K., Ishikawa E., Katakami H., and Oiso Y. Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. J. Clin. Endocrinol. Metab. 80 (1995) 1352-1356
283. Najimi M., Chigr F., Leduque P., Jordan D., Charnay Y., Chayvialle J.A., Tohyama M., and Kopp N. Immunohistochemical distribution of somatostatin in the infant hypothalamus. Brain Res. 483 (1989) 205-220
284. Najimi M., Chigr F., Jordan D., Leduque P., Bloch B., Tommasi M., Rebaud P., and Kopp N. Anatomical distribution of LHRH-immunoreactive neurons in the human infant hypothalamus and extrahypothalamic regions. Brain Res. 516 (1990) 280-291
285. Najimi M., Chigr F., Champier J., Tabib A., Kopp N., and Jodani D. Autoradiographic distribution of TRH binding sites in the human hypothalamus. Brain Res. 563 (1991) 66-76
286. Nakamura S., Kawamata T., Yasuhara O., Akiguchi I., Kimura J., Kimura H., and Kimura T. The histochemical demonstration of monoamine oxidase-containing neurons in the human hypothalamus. Neuroscience 44 2 (1991) 457-463
287. Nakamura S., Takemura M., Ohnishi K., Suenaga T., Nishimura M., Akiguchi I., Kimura J., and Kimura T. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci. Lett. 151 (1993) 196-199
288. Nakano I., and Hirano A. Loss of large neurons of the medial septal nucleus in an autopsy case of Alzheimer's disease. J. Neuropath. Exp. Neurol. 41 (1982) 341
289. Nauta W.J.H., and Haymaker W. Hypothalamic nuclei and fiber connections. In: Haymaker W., Anderson E., and Nauta W.J.H. (Eds). The Hypothalamus (1969), Charles C. Thomas, NY 136-203
290. Nilsson C., Lindvall-Axelsson M., and Owman C. Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res. Rev. 17 (1992) 109-138
291. Nobin A., and Björklund A. Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol. Scand. Suppl. 388 (1973) 1-40
292. Northcutt R.G., and Muske L.E. Multiple embryonic origins of gonadotropin-releasing hormone (GnRH) immunoreactive neurons. Dev. Brain Res. 78 (1994) 279-290
293. Okado N., and Yokota N. Axoglial synaptoid contacts in the neural lobe of the human fetus. Anat. Rec. 202 (1982) 117-124
294. Okawa M., Mishima K., Hishikawa Y., Hozumi S., Hori H., and Takahashi K. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep 14 (1991) 478-485
295. Olson B.R., Drutarosky M.D., Stricker E.M., and Verbalis J.G. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology 129 (1991) 785-791
296. Olson B.R., Drutarosky M.D., Chow M.S., Hruby V.J., Stricker E.M., and Verbalis J.G. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 12 (1991) 113-118
297. O'Neill P.A., Faragher E.B., Davies I., Wears R., McLean K.A., and Fairweather D.S. Reduced survival with increasing plasma osmolality in elderly continuing-care patients. Age and Ageing 19 (1990) 68-71
298. Oosterbaan H.P., and Swaab D.F. Amniotic oxytocin and vasopressin in relation to human fetal development and labour. Early Hum. Dev. 19 (1989) 253-262
299. Oosterbaan H.P., and Swaab D.F. Circulating neurohypophysial hormones in anencephalic infants. Am. J. Obstet. Gynecol. 157 (1987) 117-119
300. Osamura R.Y., Komatsu N., Watanabe K., Nakai Y., Tanaka I., and Imura H. Immunohistochemical and immunocytochemical localization of γ-melanocyte stimulating hormone (γ-MSH)-like immunoreactivity in human and rat hypothalamus. Peptides 3 (1982) 781-787
301. Palacios J.M., Probst A., and Mengod G. Receptor localization in the human hypothalamus. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). Progress in Brain Research. The Human Hypothalamus in Health and Disease (1992), Elsevier, Springfield, IL, USA 57-68
302. Panayotacopoulou M.T., Guntern R., Bouras C., Issidorides M.R., and Constantinidis J. Tyrosine hydroxylase-immunoreactive neurons in paraventricular and supraoptic nuclei of the human brain demonstrated by a method adapted to prolonged formalin fixation. J. Neurosci. Meth. 39 (1991) 39-44
303. Panayotacopoulou M.T., and Swaab D.F. Development of tyrosine hydroxylase-immunoreactive neurons in the human paraventricular and supraoptic nuclei. Dev. Brain Res. 72 (1993) 145-150
304. Panayotacopoulou M.T., Raadsheer F.C., and Swaab D.F. Colocalization of tyrosine hydroxylase with oxytocin or vasopressin in neurons of the human paraventricular and supraoptic nucleus. Dev. Brain Res. 83 (1994) 59-66
305. Panula P., Airaksinen M.S., Pirvola U., and Kotilainen E. Histamine containing neuronal system in human brain. Neuroscience 34 (1990) 129-132
306. Parboosingh J., Lederis K., and Singh N. Vasopressin concentration in cord blood: correlation with method of delivery and cord pH. Obstet. Gynecol. 60 (1982) 179-183
307. Parent A., Boucher R., and Reilly-Fromentin. Acetylcholinesterase-containing neurons in pallidal complex, morphologic characteristics and projection towards the neocortex. Brain Res. 230 (1981) 356-361
308. Parker G., and Walter S. Seasonal variation in depressive disorders and suicidal deaths in New South Wales. Br. J. Psychiatry 140 (1982) 626-632
309. Parker C.R., and Porter J.C. Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in the hypothalamus of women: effects of age and reproductive status. J. Clin. Endocrinol. Metab. 58 (1985) 488-491
310. Pearson R., Sofroniew M.V., Cuello A.C., Powell T.P.S., Eckenstein F., Esiri M.M., and Wilcock G.K. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer type demonstrated immunohistochemical staining for choline acetyltransferase. Brain Res. 289 (1983) 375-379
311. Pelletier G., Désy L., Lissitzky J.-C., Labrie F., and Li C.H. Immunohistochemical localization of β-LPH in the human hypothalamus. Life Sciences 22 (1978) 1799-1804
312. Pelletier G., and Désy L. Localization of ACTH in the human hypothalamus. Cell Tissue Res. 196 (1979) 525-530
313. Pelletier G., Désy L., Côté J., and Vaudry H. Immunocytochemical localization of corticotropin-releasing factor-like immunoreactivity in the human hypothalamus. Neurosci. Lett. 41 (1983) 259-263
314. Pelletier G., Desy L., Kerkerian L., and Côte J. Immunocytochemical localization of neuropeptide Y (NPY) in the human hypothalamus. Cell Tissue Res. 238 (1984) 203-205
315. Pelletier G., Désy L., Côte J., Lefèvre G., and Vaudry H. Light-microscopic immunocytochemical localization of growth hormone-releasing factor in the human hypothalamus. Cell Tissue Res. 245 (1986) 461-463
316. Pelletier G., Guy J., Désy L., Li S., Eberle A.N., and Vaudry H. Melanin-concentrating hormone (MCH) is colocalized with α-melanocyte-stimulating hormone (α-MSH) in the rat but not in the human hypothalamus. Brain Res. 423 (1987) 247-253
317. Perachio A.A., Marr L.D., and Alexander M. Sexual behavior in male rhesus monkeys elicited by electrical stimulation of preoptic and hypothalamic areas. Brain Res. 177 (1979) 127-144
318. Perry R.H., Candy J.M., Perry E.K., Irving D., Blessed G., Fairbarn A.F., and Tomlinson B.E. Extensive loss of choline acetyltransferase activity is not related by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci. Lett. 33 (1982) 311-315
319. Perry E.K. The cholinergic hypothesis 10 years on. Br. Med. Bull. 42 (1986) 63-69
320. Pfaus J.G., Kleopoulos S.P., Mobbs C.V., Gibbs R.B., and Pfaff D.W. Sexual stimulation activates c-fos within estrogen-concentrating regions of the female rat forebrain. Brain Res. 624 (1993) 253-267
321. Pilcher W.H., Joseph S.A., and McDonald J.V. Immunocytochemical localization of proopiomelanocortin neurons in human brain areas subserving stimulation analgesia. J. Neurosurg. 68 (1988) 621-629
322. Pohjavuori M., and Fyhrquist J. Hemodynamic significance of vasopressin in the newborn infant. J. Pediatr. 97 (1980) 462-465
323. Pollak C.P., and Perlick D. Sleep problems and institutionalization of the elderly. J. Geriatr. Psychiat. Neurol. 4 (1991) 204-210
324. Prader A., Labhart A., and Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Krytorchismus und Oligophrenie nach myotonieartigem Zustand in Neugeborenalter. Schweiz. Med. Wochenschr. 86 (1956) 1260-1261
325. Presse F., Sorokovsky I., Max J.P., Nicolaidis S., and Nahon J.L. Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat. Neuroscience 71 (1996) 735-745
326. Prinz P.N., and Vitiello M.V. Sleep in Alzheimer's disease. In: Alberrede J.L., Marley J.E., Roth T., and Vellas B.J. (Eds). Sleep Disorders and Insomnia in the Elderly (1993), Facts Res. Gerontol., Amsterdam 33-54
327. Pu L.P., Van Leeuwen F.W., Tracer H.L., Sonnemans M., and Loh Y.P. Localization of vasopressin mRNA and immunoreactivity in pituicytes of pituitary stalk-transected rats after osmotic stimulation. Proc. Natl. Acad. Sci. USA 92 (1995) 10653-10657
328. Purba J.S., Hofman M.A., Portegies P., Troost D., and Swaab D.F. Decreased number of oxytocin neurons in the paraventricular nucleus of the human hypothalamus in AIDS. Brain 116 (1993) 795-809
329. Purba J.S., Hofman M.A., and Swaab D.F. Decrease in number of oxytocin neurons in the paraventricular nucleus of human hypothalamus in Parkinson's disease. Neurology 44 (1994) 84-89
330. Purba J.S., Raadsheer F.C., Ravid R., Polman C.H., Kamphorst W., and Swaab D.F. Increased number of corticotropin releasing hormone (CRH) neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis. Neuroendocrinology 62 (1995) 62-70
331. Purba J.S., Hoogendijk W.J.G., Hofman M.A., and Swaab D.F. Increased number of vasopressin and oxytocin expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psych. 53 (1995) 137-143
332. Qu D., Ludwig D.S., Gammeltoft S., Piper M., Pelleymounter M.A., Cullen M.J., Foulds Mathes W., Przypek J., Kanarek R., and Maratos-Flier E. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380 (1996) 243-247
333. Raadsheer F.C., Sluiter A.A., Ravid R., Tilders F.J.H., and Swaab D.F. Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res. 615 (1993) 50-62
334. Raadsheer F.C., Oorschot D.E., Verwer R.W.H., Tilders F.J.H., and Swaab D.F. Age-related increase in the total number of corticotropin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: comparison of the disector with an unfolding method. J. Comp. Neurol. 339 (1994) 447-457
335. Raadsheer F.C., Tilders F.J.H., and Swaab D.F. Similar age-related increase of vasopressin colocalization in paraventricular corticotropin-releasing hormone neurons in controls and Alzheimer patients. J. Neuroendocrinol. 6 (1994) 131-133
336. Raadsheer F.C., Hoogendijk W.J.G., Stam F.C., Tilders F.J.H., and Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60 (1994) 436-444
337. Raadsheer F.C., Van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J.G., Tilders F.J.H., and Swaab D.F. Increased corticotropin-releasing hormone (CRF)-mRNA in the paraventricular nucleus of patients with Alzheimer's disease or depression. Am. J. Psychol. 152 (1995) 1372-1376
338. Rance N.E. Hormonal influences on morphology and neuropeptide gene expression in the infundibular nucleus of post-menopausal women. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease, Progress in Brain Research (1992), Elsevier 221-236
339. Rance N.E. Neuronal hypertrophy in the hypothalamus of older men. Neurobiol. Aging 14 (1993) 337-342
340. Rance N.E., Scott Young W., and McMullen N.T. Topography of neurons expressing luteinizing hormone-releasing hormone gene transcripts in the human hypothalamus and basal forebrain. J. Comp. Neurol. 339 (1994) 573-586
341. Raug F., Lenznert C., Nürnbergt P., Frömmel C., and Vetter U. A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus. Clin. Endocrinol. 44 (1996) 45-51
342. Ravid R., Fliers E., Swaab D.F., and Zurcher C. Changes in vasopressin and testosterone in the senescent Brown-Norway (BN/BiRij) rat. Gerontol. 33 (1987) 87-98
343. Ravid R., Van Zwieten E.J., and Swaab D.F. Brain banking and the human hypothalamus - factors to match for, pitfalls and potentials. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease. Progress in Brain Research (1992), Elsevier, Amsterdam 83-95
344. Raz N., Torres I.J., and Acker J.D. Age-related shrinkage of the mamillary bodies: in vivo MRI evidence. Neuroreport 3 (1992) 713-716
345. Raz N., Torres I.J., Briggs S.D., Spencer W.D., Thornton A.E., Loken W.J., Gunning F.M., McQuain J.D., Driesen N.R., and Acker J.D. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45 (1995) 356-366
346. Reeves A.G., and Plum F. Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm. Arch. Neurol. 20 (1969) 616-624
347. Reppert S.M. Pre-natal development of a hypothalamic biological clock. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease. Progress in Brain Research (1992), Elsevier, Amsterdam 119-132
348. Reppert S.M., Weaver D.R., and Godson C. Melatonin receptors step into the light: cloning and classification of subtypes. TiPS 17 (1996) 100-102
349. Reub J.C., Cortès R., Maurer R., Probst A., and Palacios J.M. Distribution of somatostatin receptors in the human brain: an autoradiographic study. Neuroscience 18 2 (1986) 329-346
350. Ribak C.E., and Kramer G.W. Cholinergic neurons in the basal forebrain of the cat have direct projection to the sensorimotor cortex. Expl. Neurol. 75 (1982) 453-465
351. Rinne U.K., Kivalo E., and Talanti S. Maturation of human hypothalamic neurosecretion. Biol. Neonat. 4 (1962) 351-364
352. Rinne J.O., Paljarvi L., and Rinne K. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J. Neurol. Sci. 79 (1987) 67-76
353. Rittig S., Knudsen U.B., Nørgaard J.P., Pedersen E.B., and Djurhuus J.C. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am. J. Physiol. 256 (1989) F664-F671
354. Rittig S., Robertson G.L., Siggaard C., Kovács L., Gregersen N., Nyborg J., and Pedersen E.B. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am. J. Hum. Genet. 58 (1996) 107-117
355. Rivier C., and Vale W. Interaction of corticotropin-releasing and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113 (1983) 939-942
356. Roenneberg T., and Aschoff J. Annual rhythm of human reproduction: I. Biology, sociology, or both?. J. Biol. Rhythms 5 3 (1990) 195-216
357. Rogers R.C., and Hermann G.E. Oxytocin, oxytocin antagonist, TRH, and hypothalamic paraventricular nucleus stimulation effects on gastric motility. Peptides 8 (1986) 505-513
358. Rosenthal N.E., Sack D.A., Skwerer R.G., Jacobsen F.M., and Wehr T.A. Phototherapy for seasonal affective disorder. J. Biol. Rhythms 3 2 (1988) 101-120
359. Rudelli R., and Deck J.H.N. Selective traumatic infarction of the human anterior hypothalamus. Clinical anatomical correlation. J. Neurosurg. 50 (1979) 645-654
360. Rudelli R.D., Ambler M.W., and Wisniewski H.M. Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol. 64 (1984) 273-281
361. Rusak B., and Zucker I. Neural regulation of circadian rhythms. Physiol. Rev. 59 (1979) 449-526
362. Rutishauser J., Böni-Schnetzler M., Böni J., Wichmann W., Huisman T., Vallotton M.B., and Froesch E.R. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus. J. Clin. Endocrinol. Metab. 81 (1996) 192-198
363. Sack R.L., Lewy A.J., Blood M.L., Keith L.D., and Nakagawa H. Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J. Clin. Endocrinol. Metab. 75 (1992) 127-134
364. Sadun A.A., Schaechter J.D., and Smith L. A retinohypothalamic pathway in man: light mediation of circadian rhythms. Brain Res. 302 (1984) 371-377
365. Salehi A., Lucassen P.J., Pool C.W., Gonatas N.K., Ravid R., and Swaab D.F. Nucleus basalis of Meynert and diagonal band of Broca. Neuroscience 59 (1994) 871-880
366. Salehi A., Heyn S., Gonatas N.K., and Swaab D.F. Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus. Neurosci. Lett. 193 (1995) 29-32
367. Salehi A., Van de Nes J., Hofman M.A., Gonatas N.K., and Swaab D.F. Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Brain Res. 678 (1995) 29-39
368. Salehi A., Verhaagen J., Dijkhuizen P.A., and Swaab D.F. Colocalization of high affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 75 (1996) 373-387
369. Sandyk R., Iacono R.P., and Bamford C.R. The hypothalamus in Parkinson's disease. Ital. J. Neurol. Sci. 8 3 (1987) 227-234
370. Sangruchi T., and Kowall N.W. NADPH diaphorase histochemistry of the human hypothalamus. Neuroscience 40 (1991) 713-724
371. Sanides F. Die Insulae terminales des Erwachsenengehirns des Menschen. J. Hirnforsch. 3 (1957) 243-273
372. Saper C.B., and Chelimsky T.C. A cytoarchitectonic and histochemical study of nucleus basalis and associated cell groups in the normal human brain. Neuroscience 13 4 (1984) 1023-1037
373. Saper C.B. Organization of cerebral cortical afferent systems in the rat. II Hypothalamocortical projections. J. Comp. Neurol. 237 (1985) 21-46
374. Saper C.B. Hypothalamus. In: Paxinos G. (Ed). The Human Nervous System (1990), Academic Press, Inc., Amsterdam 389-413
375. Saper C.B., and German D.C. Hypothalamic pathology in Alzheimer's disease. Neurosci. Lett. 74 (1987) 364-370
376. Sarrieau A., Najimi M., Chigr F., Kopp N., Jordan D., and Rostene W. Localization and developmental pattern of vasoactive intestinal polypeptide binding sites in the human hypothalamus. Synapse 17 (1994) 129-140
377. Satlin A., Volicer L., Ross V., Herz L., and Campbell S. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am. J. Psychiat. 149 (1992) 1028-1032
378. Satlin A., Volicer L., Stopa E.G., and Harper D. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol. Aging 16 (1995) 765-771
379. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M., Sasano H., and Mouri T. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci. Lett. 203 (1996) 207-210
380. Sawchenko P.E., and Swanson L.W. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J. Comp. Neurol. 205 (1982) 260-272
381. Schaltenbrand G., and Bailey P. Introduction to Stereotaxis with an Atlas of the Human Brain. Vol. 1 (1959), Georg Thieme Verlag, San Diego
382. Scharrer E., and Scharrer B. Secretory cells within the hypothalamus. The hypothalamus and central levels of autonomic function. Res. Publ. Assoc. Nerv. Ment. Dis. 20 (1940) 170-194
383. Scharrer E. Die Erklärung der scheinbar pathologischen Zellbilder im Nucleus supraopticus und Nucleus paraventricularis. Z. Ges. Neurol. Psychiat. 145 (1933) 462-470
384. Scherbaum W.A. Autoimmune hypothalamic diabetes insipidus ('autoimmune hypothalamitis'). In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). Progress in Brain Research, Vol. 93, The Human Hypothalamus in Health and Disease (1992), Elsevier, Stuttgart 283-293
385. Schmale H., Bahnsen U., and Richter D. Structure and expression of the vasopressin precursor gene in central diabetes insipidus. Ann. N.Y. Acad. Sci. 689 (1993) 74-82
386. Schriefer J.A., Lewis P.R., and Miller J.W. Role of fetal oxytocin in parturition in the rat. Biol. Reprod. 27 (1982) 362-368
387. Schubert F., George J.M., and Bhaskar Rao M. Vasopressin and oxytocin content of human fetal brain at different stages of gestation. Brain Res. 213 (1981) 111-117
388. Schumacher M., Coirini H., Pfaff D.W., and McEwen B.S. Behavioral effects of progesterone associated with rapid modulation of oxytocin receptors. Science 250 (1990) 691-694
389. Schvarcz J.R., Driollet R., Rios E., and Betti O. Stereotactic hypothalamotomy for behaviour disorders. J. Neurol. Neurosurg. Psychiatry 35 (1972) 356-359
390. Schwanzel-Fukuda M., Bick D., and Pfaff D. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol. Brain Res. 6 (1989) 311-326
391. Schwanzel-Fukuda M., Crossin K.L., Pfaff D.W., Bouloux P.M.G., Hardelin J.-P., and Petit C. Migration of luteinizing hormone-releasing hormone (LHRH) neurons in early human embryos. J. Comp. Neurol. 366 (1996) 547-557
392. Schwartz W.J., Bosis N.A., and Hedley-Whyte E.T. A discrete lesion of ventral hypothalamus and optic chiasm that disturbed the daily temperature rhythm. J. Neurol. 233 (1986) 1-4
393. Scott S.A., Mufson E.J., Weingartner J.A., Skau K.A., and Crutcher K.A. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci. 15 (1995) 6213-6221
394. Sheehan H.L., and Kovacs K. The subventricular nucleus of the human hypothalamus. Brain 89 (1966) 589-614
395. Shelton D.L., Sutherland J., Gripp J., Camerato T., Armanini M.P., Phillips H.S., Carroll K., Spencer S.D., and Levinson A.D. Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J. Neurosci. 15 (1995) 477-491
396. Sherin J.E., Shiromani P.J., McCarley R.W., and Saper C.B. Activation of ventrolateral preoptic neurons during sleep. Science 271 (1996) 216-219
397. Simerly R.B., Gorski R.A., and Swanson L.W. Neurotransmitter specificity of cells and fibers in the medial preoptic nucleus: an immunohistochemical study in the rat. J. Comp. Neurol. 246 (1986) 343-362
398. Simpson W.A., Yates C.M., Watts A.G., and Fink G. Congo red birefringent structures in the hypothalamus in senile dementia of the Alzheimer type. Neuropathol. Appl. Neurobiol. 14 (1988) 381-393
399. Skowsky W.R., and Fisher D.A. Fetal neurohypophyseal arginine vasopressin and arginine vasotocin in man and sheep. Pediatr. Res. 11 (1977) 627-630
400. Smeets D.F.C.M., Hamel B.C.J., Smeets H.J.M., Bollen J.H.M., Smits A., Ropers H.H., and Van Oost B.A. Prader-Willi syndrome and Angelman syndrome in cousins from a family with a translocation between chromosomes 6 and 15. New Engl. J. Med. 326 (1992) 807-811
401. Sofroniew M.V. Projections from vasopressin, oxytocin, and neurophysin neurons to neural targets in the rat and human. J. Histochem. Cytochem. 28 (1980) 475-478
402. Sparks D.L., and Hunsaker J.C. The pineal gland in sudden infant death syndrome: preliminary observations. J. Pin. Res. 5 (1988) 111-118
403. Sparks D.L., and Hunsaker J.C. Sudden infant death syndrome: altered aminergic-cholinergic synaptic markers in hypothalamus. J. Child Neurol. 6 (1991) 335-339
404. Sparks D.L., Woeltz V.M., and Markesbery W.R. Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. Arch. Neurol. 48 (1991) 718-721
405. Spencer S., Saper C.B., Joh T., Reis D.J., Goldstein M., and Raese J.D. Distribution of catecholamine-containing neurons in the normal human hypothalamus. Brain Res. 328 (1985) 73-80
406. Standaert D.G., Lee V.-Y., Greenberg B.D., Lowery D.E., and Trojanowski J.Q. Molecular features of hypothalamic plaques in Alzheimer's disease. Am. J. Pathol. 139 3 (1991) 681-691
407. Staudt J., and Stüber P. Morphologische Untersuchungen der Matrix im Bereich des Hypothalamus beim Menschen. Z. Mikrosk.-Anat. Forsch., Leipzig 91 4S (1977) 773-786
408. Steinbusch H.W.M., and Mulder A.H. Localization and projections of histamine immunoreactive neurons in the central nervous system of the rat. In: Björklund A., Hökfelt T., and Kuhar M.J. (Eds). Handbook of Chemical Neuroanatomy 3 (1984), Elsevier, Amsterdam 126-140
409. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., and Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mouse: a genetic model of anxiogenic behavior. J. Neurosci. 14 (1994) 2579-2584
410. Stern B.J., Krumholz A., Johns C., Scott P., and Nissim J. Sarcoidosis and its neurological manifestations. Arch. Neurol. 42 (1985) 909-917
411. Stevens J.R. Neuropathology of schizophrenia. Arch. Gen. Psychiatry 39 (1982) 1131-1139
412. Stopa E.G., Koh E.T., Svendsen C.N., Rogers W.T., Schwaber J.S., and King J.C. Computer-assisted mapping of immunoreactive mammalian gonadotropin-releasing hormone in adult human basal forebrain and amygdala. Endocrinology 128 6 (1991) 3199-3207
413. Strenge H. Über den Nucleus tuberis lateralis im Gehirn des Menschen. Eine pigmentarchitektonische Studie. Z. Mikrosk.-Anat. Forsch., Leipzig 89 6 S (1975) 1043-1067
414. Sturner W.Q., Lynch H.J., Deng M.H., Gleason R.E., and Wurtman R.J. Melatonin concentrations in the sudden infant death syndrome. Forensic Sci. Int. 45 (1990) 171-180
415. Sukhov R.R., Walker L.C., Rance N.E., Price D.L., and Scott Young III W. Opioid precursor gene expression in the human hypothalamus. J. Comp. Neurol. 353 (1995) 604-622
416. Swaab D.F., and Jongkind J.F. Influence of gonadotropic hormones on the hypothalamic neurosecretory activity in the rat. Neuroendocrinology 8 (1971) 36-47
417. Swaab D.F., Jongkind J.F., and De Ryke-Arkenbout A.A. Quantitative histochemical study on the influence of lactation and changing levels of gonadotropic hormones on rat supraoptic nucleus. Endocrinology 89 (1971) 1123-1125
418. Swaab D.F., Boer K., and Honnebier W.J. The influence of the fetal hypothalamus and pituitary on the onset and course of parturition. In: Knight J., and O'Connor M. (Eds). The Fetus and Birth, Ciba Foundation Symposium (1977), Elsevier/North-Holland Biomedical Press, Amsterdam 379-400
419. Swaab D.F., Boer G.J., Boer K., Oosterbaan H.P., and Oosting P.R. Neurohypophysial and intermediate lobe peptides in intrauterine growth and labour. In: Baertsch A.J., and Dreifuss J.J. (Eds). Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortins (1982), Academic Press, Amsterdam-New York 343-352
420. Swaab D.F., and Fliers E. A sexually dimorphic nucleus in the human brain. Science 228 (1985) 1112-1115
421. Swaab D.F., Fliers E., and Partiman T.S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342 (1985) 37-44
422. Swaab D.F., Roozendaal B., Ravid R., Velis D.N., Gooren L., and Williams R.S. Suprachiasmatic nucleus in aging, Alzheimer's disease, transsexuality and Prader-Willi syndrome. In: De Kloet R., et al. (Ed). Neuropeptides and Brain Function, Progress in Brain Research (1987), Elsevier, London 301-310
423. Swaab D.F., Fliers E., and Hoogendijk J.E. Vasopressin in relationship to human aging and dementia. In: Gash D.M., and Boer G.J. (Eds). Vasopressin: Principles and Properties (1987), Plenum Press, Amsterdam 611-625
424. Swaab D.F., and Hofman M.A. Sexual differentiation of the human hypothalamus: ontogeny of the sexually dimorphic nucleus of the preoptic area. Dev. Brain Res. 44 (1988) 314-318
425. Swaab D.F., and Hofman M.A. An enlarged suprachiasmatic nucleus in homosexual men. Brain Res. 537 (1990) 141-148
426. Swaab D.F., Hofman M.A., and Honnebier M. Development of vasopressin neurons in the human suprachiasmatic nucleus in relation to birth. Dev. Brain Res. 52 (1990) 289-293
427. Swaab D.F. Brain aging and Alzheimer's disease: 'wear and tear' versus 'use it or lose it'. Neurobiol. Aging 12 (1991) 317-324
428. Swaab D.F., Eikelenboom P., Grundke-Iqbal I., Iqbal K., Kremer H.P.H., Ravid R., and Van de Nes J. Cytoskeletal alterations in the hypothalamus during aging and in Alzheimer's disease are not necessarily a marker for impending cell death. In: Iqbal K., McLachlan D.R.C., Winblad B., and Wisniewski H.M. (Eds). Alzheimer's disease: Basic mechanisms, diagnosis and therapeutic strategies (1991), John Wiley and Sons, New York 181-190
429. Swaab D.F., Gooren L.J.G., and Hofman M.A. The human hypothalamus in relation to gender and sexual orietation. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). The Human Hypothalamus in Health and Disease, Progress in Brain Research (1992), Elsevier, New York 205-215
430. Swaab D.F., Grundke-Iqbal I., Iqbal K., Kremer H.P.H., Ravid R., and Van de Nes J. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease. Brain Res. 590 (1992) 239-249
431. Swaab D.F., Hofman M.A., Lucassen P.J., Salehi A., and Uylings H.B.M. Neuronal shrinkage is the major hallmark in Alzheimer's disease. Neurobiol. Aging 15 (1994) 369-371
432. Swaab D.F., Zhou J.N., Ehlhart T., and Hofman M.A. Development of vasoactive intestinal polypeptide (VIP) neurons in the human suprachiasmatic nucleus (SCN) in relation to birth and sex. Dev. Brain Res. 79 (1994) 249-259
433. Swaab D.F. Aging of the human hypothalamus. Horm. Res. 43 (1995) 8-11
434. Swaab D.F. Development of the human hypothalamus. Neurochem. Res. 20 (1995) 509-519
435. Swaab D.F., and Hofman M.A. Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. TINS 18 (1995) 264-270
436. Swaab D.F., Purba J.S., and Hofman M.A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J. Clin. Endocrinol. Metab. 80 (1995) 573-579
437. Swaab D.F., Slob A.K., Houtsmuller E.J., Brand T., and Zhou J.N. Increased number of vasopressin neurons in the suprachiasmatic nucleus (SCN) of 'bisexual' adult male rats following perinatal treatment with the aromatase blocker ATD. Dev. Brain Res. 85 (1995) 273-279
438. Swanson L.W., Sawchenko P.E., Rivier J., and Vale W.W. Organisation of ovine corticotropin releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 37 (1983) 165-186
439. Tagliavini F., Pilleri G., Gemigoni F., and Lechi A. Neuron loss in the basal nucleus of Meynert in progressive supranuclear palsy. Acta Neuropath. Berlin 61 (1983) 157-160
440. Tagliavini F., and Pilleri G. A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntingdon chorea. J. Neurol. Sci. 62 (1983) 243-260
441. Tago H., McGeer P.L., Bruce G., and Hersh L.B. Distribution of choline acetyltransferase-containing neurons of the hypothalamus. Brain Res. 415 (1987) 49-62
442. Takahashi K., Mouri T., Sone M., Murakami O., Itoi K., Imai Y., Ohneda M., Yoshinaga K., and Sasano N. Calcitonin gene-related peptide in the human hypothalamus. Endocrinol. Jpn. 36 3 (1989) 409-415
443. Takahashi K., Totsune K., Murakami O., Satoh F., Sone M., Ohneda M., Sasano H., and Mouri T. Pituitary adenylate cyclase activating polypeptide (PACAP)-like immunoreactivity in human hypothalamus: colocalization with arginine vasopressin. Reg. Pept. 50 (1994) 267-275
444. Thalén B.E., Kjellman B.F., Mørkrid L., Wibom R., and Wetterberg L. Light treatment in seasonal and nonseasonal depression. Acta. Psychiatr. Scand. 19 (1995) 352-360
445. Ticher A., Sackett-Lundeen L., Ashkenazi I.E., and Haus E. Human circadian time structure in subjects of different gender and age. Chronobiol. Int. 11 6 (1994) 349-355
446. (in press). Timmers H.J.L.M., Swaab D.F., Van de Nes J., and Kremer H.P.H. Somatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington's disease patients. Brain Res. (1996)
447. Torvik A., Lindboe C.F., and Rogde S. Brain lesions in alcoholics. J. Neurol. Sci. 56 (1982) 233-248
448. Touitou Y. Adrenocortical hormones, ageing and mental condition: seasonal and circadian rhythms of plasma 18-hydroxy-11-deoxycorticosterone, total and free cortisol and urinary corticosteroids. J. Endocrinol. 96 (1983) 53-64
449. Touitou Y. Effects of aging on endocrine and neuroendocrine rhythms in humans. Horm. Res. 43 (1995) 12-19
450. Treip C.S. The hypothalamus and pituitary gland. In: Hume A.J., and Duchen L.W. (Eds). Greenfield's Neuropathology (1992), Edward Arnold, Amsterdam 1046-1062
451. Trick G.L., Barris M.C., and Bickler-Bluth M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann. Neurol. 26 (1989) 226-231
452. Turkenburg J.L., Swaab D.F., Endert E., Louwerse A.L., and Van de Poll N.E. Effects of lesions of the sexually dimorphic nucleus on sexual behaviour of testosterone-treated female Wistar rats. Brain Res. Bull. 21 (1988) 215-224
453. Uchida K., Okamoto N., Ohara K., and Morita Y. Daily rhythm of serum melatonin in patients with dementia of the degenerate type. Brain Res. 717 (1996) 154-159
454. Uhl G.R., Hilt D.C., Hedreen J.C., Whitehouse P.J., and Price D.L. Pick's disease (labor sclerosis), depletion of neurons in the nucleus basalis of Meynert. Neurology 33 (1983) 1470-1473
455. Ule G., Schwechheimer K., and Tschahargane C. Morphological feedback effect on neurons of the nucl. arcuatus (sive infundibularis) and nucl. subventricularis hypothalami due to gonadal atrophy. Virchows Arch. 400 (1983) 297-308
456. Ule G., and Walter C. Morphological feedback effect on the nucleoli of the neurons in the nucleus arcuatus (infundibularis) to hypophyseal hypogonadism in juvenile haemochromatosis. Acta Neuropathol. 61 (1983) 81-84
457. Ulfig N., and Braak H. Amyloid deposits and neurofibrillary changes in the hypothalamic tuberomamillary nucleus. J. Neural Transm. (P.D. Sect) 1 (1984) 143
458. Ulfig N., Braak E., Ohm T.G., and Pool C.W. Vasopressinergic neurons in the magnocellular nuclei of the human basal forebrain. Brain Res. 530 (1990) 176-180
459. Unger J.W., and Lange W. Immunohistochemical mapping of neurohypophysins and calcitonin generelated peptide in the human brainstem and cervical spinal cord. J. Chem. Neuroanat. 4 (1991) 299-309
460. Vale W.W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213 (1981) 1394-1397
461. Vale W.W., Vaughan J., Smith M., Yamamoto G., Rivier J., and Rivier C. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology 113 (1983) 1121-1131
462. Vallet P.G., Charnay Y., and Bouras C. Distribution and colocalization of delta sleep-inducing peptide and luteinizing hormone-releasing hormone in the aged human brain: an immunohistochemical study. J. Chem. Neuroanat. 3 (1990) 207-214
463. Van de Nes J., Kamphorst W., Ravid R., and Swaab D.F. The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients. Brain 116 (1993) 103-115
464. Van de Nes J., Sluiter A.A., Pool C.W., Kamphorst W., Ravid R., and Swaab D.F. The monoclonal antibody Alz-50, used to reveal cytoskeletal changes in Alzheimer's disease, also reacts with a large subpopulation of somatostatin neurons in the normal human hypothalamus and adjoining areas. Brain Res. 655 (1994) 97-109
465. Offered. Van de Nes J., Kamphorst W., Boon M., Ravid R., and Swaab D.F. Comparison of Alz-50, Beta-protein/A4 and somatostatin-like immunoreactivity in the hypothalamic nucleus tuberalis lateralis of Alzheimer's disease and demented Down's syndrome patients (1996)
466. Van der Beek E.M., Wiegant V.M., Van der Donk H.A., Van den Hurk R., and Buijs R.M. Lesions of the suprachiasmatic nucleus indicate the presence of a direct VIP containing projection to gonadotropin-releasing hormone neurons in the female rat. J. Neuroendocrinol. 5 (1993) 137-144
467. Van der Woude P.F., Goudsmit E., Wierda M., Purba J.S., Hofman M.A., Bogte H., and Swaab D.F. No vasopressin cell loss in the human paraventricular and supraoptic nucleus during aging and in Alzheimer's disease. Neurobiol. Aging 16 (1995) 11-18
468. (in press). Van Someren E., Hagebeuk E., Lijzenga C., Scheltens P., De Rooij S., Jonker C., Pot A.-M., Mirmiran M., and Swaab D.F. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol. Psychiatry (1996)
469. Van Zwieten E.J., Ravid R., Hoogendijk W., and Swaab D.F. Stable vasopressin innervation in the degenerating human locus coeruleus in Alzheimer's disease. Brain Res. 649 (1994) 329-333
470. Veith R.C., Lewis N., Langohr J.I., Murburg M.M., Ashleigh E.A., Castillo S., Peskind E.R., Pascualy M., Bissette G., Nemeroff C.B., and Raskind M.A. Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects. Psychiat. Res. 46 (1993) 1-8
471. Vermeulen A. Androgens and male senescence. In: Nieschlag E., and Behre H.M. (Eds). Testosterone. Action, Deficiency, Substitution (1990), Springer Verlag, London 629-645
472. Visser M., and Swaab D.F. Life span changes in the presence of melanocyte stimulating hormone containing cells in the human pituitary. J. Dev. Physiol. 1 (1979) 161-178
473. Vogels O., Broere C., Ter Laak H.J., Ten Donkelaar H.J., Nieuwenhuys R., and Schulte B.P.M. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging 11 (1990) 3-13
474. Von den Velden R. Die Nierenwirkung van Hypophyse-extrakten bei Menschen. Berl. Klin. Wschr. 50 (1913) 2083-2086
475. Volumes 1 to 3. Königsberg. Von Baer K.E. Ueber die Entwicklungsgeschichte der Tiere (1837)
476. Voorn P., and Buijs R.M. An immuno-electronmicroscopical study comparing vasopressin, oxytocin, substance P and enkephalin containing nerve terminals in the nucleus of the solitary tract of the rat. Brain Res. 270 (1983) 169-173
477. Walter A., Mai J.K., and Jiménez-Härtel W. Mapping of neuropeptide Y-like immunoreactivity in the human forebrain. Brain Res. Bull. 24 (1990) 297-311
478. Walter A., Mai J.K., Lanta L., and Görcs T. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J. Chem. Neuroanat. 4 (1991) 281-298
479. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., and Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 295 (1984) 13-25
480. Weaver D.R., Stehle J.H., Stopa E.G., and Reppert S.M. Melatonin receptors in human hypothalamus and pituitary: implications for circadian and reproductive responses to melatonin. J. Clin. Endocrinol. Metab. 76 (1993) 295-301
481. Wharton R.H., and Bresman M.J. Neonatal respiratory depression and delay in diagnosis in Prader-Willi syndrome. Dev. Med. Child Neurol. 31 (1989) 231-236
482. White L.E., and Hain R.F. Anorexia in association with a destructive lesion of the hypothalamus. Arch. Pathol. 68 (1959) 275-281
483. Whitehouse P.J., Price D.L., Clark A.W., Coyl J.R., and Delong M.R. Alzheimer's disease, evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10 (1981) 122-126
484. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., and Delong M.R. Alzheimer's disease and senile dementia; loss of neurons in the basal forebrain. Science 215 (1982) 1237-1239
485. Whitehouse P.J., Parhad I.M., Hedreen J.C., Clark A.W., White C.L., Stuble R.G., and Price D.L. Integrity of the nucleus basalis of Meynert in normal aging. Neurology 33 Suppl. 2 (1983) 159
486. Whitehouse P.J., Hedreen J.C., Jones B.E., and Price D.L. A computer analysis of neuronal size in the nucleus basalis of Meynert in patients with Alzheimer's disease. Ann. Neurol. 14 (1983) 149-150
487. Whitehouse P.J., Hedreen J.C., White III C.L., and Price D.L. Basal forebrain neurons in the dementia of Parkinson's disease. Ann. Neurol. 13 (1983) 243-248
488. Whitnall M.H., Kiss A., and Aguilera G. Contrasted effects of central alpha-1 adrenoreceptor activation on stress-responsive and stress non-responsive subpopulations of corticotropin-releasing hormone neurosecretory cells in the rat. Neuroendocrinology 58 (1993) 42-48
489. Wierda M., Goudsmit E., Van der Woude P.F., Purba J.S., Hofman M.A., Bogte H., and Swaab D.F. Oxytocin cell number in the human paraventricular nucleus remains constant with aging and in Alzheimer's disease. Neurobiol. Aging 12 (1991) 511-516
490. 3H-prazosin binding sites in the supraoptic and paraventricular nuclei of the human hypothalamus. Neuroendocrinology 51 (1990) 315-319
491. Wirz-Justice A., Graw P., Kräuchi K., Gisin B., Jochum A., Arendt J., Fisch H.-U., Buddeberg C., and Pöldinger W. Light therapy in seasonal affective disorder is independent of time of day or circadian phase. Arch. Gen. Psychiatry 50 (1993) 929-937
492. Wisniewski K.E., and Bobinski M. Hypothalamic abnormalities in Down syndrome. The Morphogenesis of Down Syndrome (1991), Wiley-Liss Inc., Berlin 153-167
493. Witting W., Kwa I.H., Eikelenboom P., Mirmiran M., and Swaab D.F. Alterations in the circadian restactivity rhythm in aging and Alzheimer's disease. Biol. Psychiatry 27 (1990) 563-572
494. Yuasa H., Ito M., Nagasaki H., Oiso Y., Miyamoto S., Sasaki N., and Saito H. Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus. J. Clin. Endocrinol. Metab. 77 (1993) 600-604
495. Zecevic N., and Verney C. Development of the catecholamine neurons in human embryos and fetuses, with special emphasis on the innervation of the cerebral cortex. J. Comp. Neurol. 351 (1995) 509-535
496. Zhou J.N., Hofman M.A., and Swaab D.F. No changes in the number of vasoactive intestinal polypeptide (VIP)-expressing neurons in the suprachiasmatic nucleus of homosexual men; comparison with vasopressin-expressing neurons. Brain Res. 672 (1995) 285-288
497. Zhou J.N., Hofman M.A., and Swaab D.F. VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol. Aging 16 (1995) 571-576
498. Zhou J.N., Hofman M.A., Gooren L.J.G., and Swaab D.F. A sex difference in the human brain and its relation to transsexuality. Nature 378 (1995) 68-70